|
Pompe Program Update
|
Genzyme |
|
Extraordinary Measures Press Release
|
IPA |
|
IPA/Erasmus MC Pompe Patient Questionnaire - an Update
|
IPA |
|
Pompe Program Update
|
Genzyme |
|
Influenza Vaccinations and Pompe Disease
|
IPA |
|
Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
|
Amicus |
|
IPA Feedback Survey: Response to Myozyme Supply Disruption
|
IPA |
|
Pompe Program Update
|
Genzyme |
|
Genzyme Submits All Information Requested by FDA for Lumizyme
|
Genzyme |
|
IPA Statement: The End of Myozyme Supply Restrictions
|
IPA |
